Home About us Services Contact
 

News

OXB announced a new Commercial Supply Agreement with Bristol Myers Squibb (BMS) to manufacture and supply lentiviral vectors for BMS’ CAR‑T programmes. The partnership, originally established in 2020, will shift to commercial production in 2026, pending regulatory approval. The multi‑year deal is projected to generate significant revenue, reinforci...
Full article
05/02/2026 | Oxford Biomedica plc
Cars Commerce Inc. (NYSE: CARS) announced a partnership with Del Grande Dealer Group and Salesforce to launch DealerCloud LLC, a new automotive CRM built on Salesforce’s Agentforce Automotive platform. The solution targets long‑standing inefficiencies in auto‑retail CRMs by offering a modern, intuitive system that merges data across OEMs, retailers...
Full article
05/02/2026 | Cars.com Inc.
Wall Street analysts anticipate a year‑over‑year earnings decline for Porch Group, Inc. (PRCH) in the quarter ended December 2025. The consensus EPS estimate is –$0.07 per share, a 146.7 % drop from the same period last year. Revenues are projected at $108.64 million, up 8.3 % from the previous quarter. The Zacks Earnings ESP model signals a negati...
Full article
05/02/2026 | Porch Group, Inc.
The appointment comes as Cadiz positions itself to meet rising demand for clean water and energy resources. The company controls 45,000 acres of land in California, 2.5 million acre‑feet of water supply, and 220 miles of pipeline assets. With O’Hara’s guidance, Cadiz aims to address climate‑change‑related challenges to water access and accelerate s...
Full article
05/02/2026 | Cadiz Inc.
Cadiz, Inc. (NASDAQ: CDZI) has added Dave O’Hara to its Board of Directors. O’Hara, a veteran finance executive, spent more than two decades at Microsoft, where he served as Executive Vice President and Chief Financial Officer of the Commercial Business Group. His experience in corporate finance, commercial strategy, and large‑scale capital‑intensi...
Full article
05/02/2026 | Cadiz Inc.
Embla Medical reported Q4 2025 sales of USD 257 million, up 14% in USD terms and 10% in local currency, with organic growth of 7% versus 5% in Q4 2024. FY 2025 organic sales growth was 6%. EBITDA margin for the quarter fell to 19% from 21% due to FX, tariffs, and initiatives aimed at long‑term profitability in Patient Care. Net profit rose 33% to U...
Full article
04/02/2026 | Embla Medical hf
NVZMY holds a Zacks Rank of #2 (Buy) versus HWKN’s #3 (Hold), reflecting a sharper earnings‑outlook improvement for the former. Forward‑looking valuation multiples reinforce NVZMY’s relative appeal: its forward P/E sits at 24.53 compared with HWKN’s 31.23, and its PEG ratio is 1.11 against HWKN’s 1.95. The price‑to‑book metric also favours NVZMY, w...
Full article
04/02/2026 | Novozymes A/S
Liberty’s CEO Mike Fries described the collaboration as a “significant milestone” that will generate substantial value for stakeholders. Google Cloud’s EMEA president Tara Brady highlighted the goal of cutting complexity and delivering tangible customer benefits. While financial terms were not disclosed, analysts view the alliance as a transformati...
Full article
04/02/2026 | Liberty Global Ltd.
The alliance also explores running Google Cloud services inside Liberty’s own data centres, addressing European data‑sovernity concerns while potentially increasing capacity for excess customer demand. Liberty will begin offering Google products such as Pixel phones, smart‑watch devices, and YouTube Premium, creating fresh revenue streams and expan...
Full article
04/02/2026 | Liberty Global Ltd.
Liberty Global Ltd. (LBTYA) announced a five‑year strategic partnership with Google Cloud that will embed Google’s Gemini AI models across its European network. The deal focuses on three priorities: AI‑driven customer value, cloud optimisation, and new growth opportunities. Gemini will be integrated into the company’s Horizon TV platform, turning c...
Full article
04/02/2026 | Liberty Global Ltd.